verapamil hydrochloride
- Product NDC
- 70934-902
- 11-digit product format
- 709340902
- Labeler code
- 70934
- Product ID
- 70934-902_cd50a0f4-94cc-738d-e053-2a95a90a4a9e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- verapamil hydrochloride
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA090700
- Marketing category
- ANDA
- Marketing start
- 2021-09-28
- Marketing end
- 0000-00-00
- Substance
- VERAPAMIL HYDROCHLORIDE
- Active strength
- 180 mg/1
- Pharmacologic classes
- P-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-902-30 | 70934090230 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70934-902-30) | 2021-09-28 | 0000-00-00 | No | No | Current |